| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5597 | 92-84-2 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 133.52 | 86.40 | 37 | 144 | 145636 | 63343205 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 112.04 | 52.42 | 43 | 368 | 245724 | 79498253 |
| Cardio-respiratory arrest | 56.22 | 52.42 | 21 | 390 | 108489 | 79635488 |
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| CHEBI has role | CHEBI:48578 | free radical scavengers |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:173084 | ferroptosis inhibitors |
None
| Species | Use | Relation |
|---|---|---|
| Horses | Removal of bots, Gastrophilus nasalis | Indication |
| Horses | Removal of bots, Gastrophilus intestinalis | Indication |
| Horses | Removal of large strongyles, Strongylus vulgaris | Indication |
| Horses | Removal of small strongyles | Indication |
| Horses | Removal of large roundworms, Parascaris equorum | Indication |
| Horses | Removal of pinworms, Oxyuris equi | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Dyrex T.F - 1000, Dyrex T.F - 200, Dyrex T.F - 500 | Zoetis Inc. | 3 |
| Parvex Plus Suspension | Zoetis Inc. | 2 |
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 | Enzyme | IC50 | 6.27 | CHEMBL | |||||
| Cannabinoid receptor 1 | GPCR | Ki | 4.71 | CHEMBL | |||||
| Prostaglandin G/H synthase 1 | Enzyme | IC50 | 6.71 | CHEMBL | |||||
| Sodium-dependent noradrenaline transporter | Transporter | IC50 | 6.34 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.93 | CHEMBL | |||||
| Sodium-dependent dopamine transporter | Transporter | Ki | 4.83 | CHEMBL | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.84 | CHEMBL | |||||
| Acetylcholinesterase | Enzyme | IC50 | 5.14 | CHEMBL | |||||
| Cholinesterase | Enzyme | IC50 | 5.24 | CHEMBL | |||||
| Cytochrome P450 1A2 | Enzyme | IC50 | 7.80 | CHEMBL | |||||
| Amine oxidase [flavin-containing] A | Enzyme | IC50 | 6.23 | CHEMBL | |||||
| Alpha-synuclein | Transporter | IC50 | 4.58 | CHEMBL | |||||
| Arachidonate 15-lipoxygenase | Enzyme | IC50 | 5.33 | CHEMBL | |||||
| Arachidonate 5-lipoxygenase | Enzyme | IC50 | 5.85 | CHEMBL |
| ID | Source |
|---|---|
| CHEBI:37932 | CHEBI |
| CHEMBL828 | ChEMBL_ID |
| C031637 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11447 | DRUGBANK_ID |
| C0031436 | UMLSCUI |
| 4173 | INN_ID |
| 372839006 | SNOMEDCT_US |
| 765430004 | SNOMEDCT_US |
| D02601 | KEGG_DRUG |
| 7108 | PUBCHEM_CID |
| GS9EX7QNU6 | UNII |
None